Literature DB >> 8699867

Regulatory effects of pentoxifylline on T-helper cell-derived cytokine production in human blood cells.

N Benbernou1, S Esnault, G Potron, M Guenounou.   

Abstract

Pentoxifylline (PTX), a methyl xanthine derivative, was examined for its regulatory effect on Th1-and Th2-cell-derived cytokines in human whole blood and peripheral blood mononuclear cells stimulated with phytohemagglutinin (PHA) and phorbol myristate acetate (PMA). Cytokine production was analyzed by enzyme-linked immunosorbent assay and cytokine mRNA expression was examined by the polymerase chain reaction (PCR) after reverse transcription (RT). The results showed that PTX at 5 x 10(-4) M concentration selectively suppressed Th-1 cytokines [interleukin-2 (IL-2) and interferon-gamma (IFN-gamma)] but not IL-4, as observed by the measurement of protein secretion. Using sensitive RT-PCR assays, data show that at this same PTX concentration (5 x 10(-4) M), these cells also exhibited inhibition in the expression of IL-4 and IL-10 mRNA, together with inhibition of IL-2 and IFN-gamma mRNA expression. At 1 x 10(-4) M, no apparent change in IL-4 and IL-10 mRNA expression was observed, whereas IL-2 mRNA was still inhibited. It was noted that PTX at 1 x 10(-3) M induced a generalized inhibition of all cytokines. Our findings showed that PTX at the appropriate concentrations could induce selective suppression of IL-2 and IFN-gamma, whereas at high concentrations this drug could act as a suppressive agent of both Th1- and Th2-derived cytokines. Moreover, these data provide further evidence that the induction of IL-2 gene transcription is highly sensitive to an elevation of cAMP, whereas IL-4 gene transcription appeared to be less affected.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8699867     DOI: 10.1097/00005344-199500252-00016

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  7 in total

1.  Differential regulation of IFN-gamma, IL-10 and inducible nitric oxide synthase in human T cells by cyclic AMP-dependent signal transduction pathway.

Authors:  N Benbernou; S Esnault; H C Shin; H Fekkar; M Guenounou
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

2.  Different regulatory effects of pentoxifylline on human T cell activation pathways.

Authors:  R P Dong; Y Umezawa; H Ikushima; Y Munakata; S F Schlossman; C Morimoto
Journal:  J Clin Immunol       Date:  1997-05       Impact factor: 8.317

3.  Low hemoglobin levels and an increased risk of psoriasis in patients with chronic kidney disease.

Authors:  Si-Hyung Lee; Miri Kim; Kyung-Do Han; Ji Hyun Lee
Journal:  Sci Rep       Date:  2021-07-20       Impact factor: 4.379

4.  Oxpentifylline versus placebo in the treatment of erythropoietin-resistant anaemia: a randomized controlled trial.

Authors:  David Wayne Johnson; Carmel Mary Hawley; Brenda Rosser; Elaine Beller; Charles Thompson; Robert G Fassett; Paolo Ferrari; Stephen MacDonald; Eugenie Pedagogos; Alan Cass
Journal:  BMC Nephrol       Date:  2008-08-01       Impact factor: 2.388

5.  Administration of pentoxifylline to improve anemia of hemodialysis patients.

Authors:  Heshmatolah Shahbazian; Ali Ghorbani; Azita Zafar-Mohtashami; Abdolreza Balali; Armaghan AleAli; Gholam Reza Lashkarara
Journal:  J Renal Inj Prev       Date:  2016-11-26

Review 6.  The Influence of Inflammation on Anemia in CKD Patients.

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Robert Olszewski; Jacek Rysz
Journal:  Int J Mol Sci       Date:  2020-01-22       Impact factor: 5.923

7.  Effects of pentoxifylline on whole blood IL-2 and IFN-gamma gene expression in normal dogs.

Authors:  Evangel Kummari; Andres Gibbs; Caitlin Riggs; Claire Fellman; John Stokes; John Thomason; Robert Wills; Andrew Mackin; Todd Archer
Journal:  Vet Med Sci       Date:  2019-10-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.